We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+0.76%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$30.7B
AUM Growth
-$701M
(-2.2%)
Cap. Flow
-$734M
Cap. Flow
% of AUM
-2.39%
Top 10 Holdings %
Top 10 Hldgs %
26.64%
Holding
969
New
40
Increased
169
Reduced
587
Closed
106
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$252M |
| 2 |
Costco
COST
|
+$107M |
| 3 |
Amazon
AMZN
|
+$69.7M |
| 4 |
W.P. Carey
WPC
|
+$55.3M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$48.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WFM
Whole Foods Market Inc
WFM
|
+$144M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$119M |
| 3 |
Gilead Sciences
GILD
|
+$113M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$95.8M |
| 5 |
DaVita
DVA
|
+$91M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.51% |
| 2 | Healthcare | 18.91% |
| 3 | Financials | 13.44% |
| 4 | Consumer Discretionary | 11.16% |
| 5 | Industrials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Visa
V
$678B
| $992M | 3.23% |
14,777,368
-1,048,489
| -7% | -$71.1M |
|
|
ESRX
2
DELISTED
Express Scripts Holding Company
ESRX
| $979M | 3.19% |
11,002,598
-1,366,638
| -11% | -$119M |
|
|
SCHW
3
Charles Schwab
SCHW
$174B
| $935M | 3.05% |
28,646,491
-3,031,825
| -10% | -$95.8M |
|
4
Apple
AAPL
$4.79T
| $894M | 2.91% |
28,509,948
-1,486,276
| -5% | -$47.5M |
|
|
5
Amazon
AMZN
$2.65T
| $793M | 2.58% |
36,521,020
+3,335,300
| +10% | +$69.7M |
|
6
Starbucks
SBUX
$120B
| $785M | 2.56% |
14,638,423
-483,951
| -3% | -$24.6M |
|
7
Alphabet (Google) Class C
GOOG
$4.25T
| $779M | 2.54% |
29,379,260
-679,119
| -2% | -$18.2M |
|
8
Meta Platforms (Facebook)
META
$1.61T
| $707M | 2.3% |
8,243,124
+291,609
| +4% | +$23.8M |
|
|
SRCL
9
DELISTED
Stericycle Inc
SRCL
| $663M | 2.16% |
4,952,740
-157,965
| -3% | -$21.7M |
|
10
Danaher
DHR
$124B
| $656M | 2.14% |
11,400,458
-347,048
| -3% | -$19.9M |
|
11
Intuitive Surgical
ISRG
$123B
| $616M | 2.01% |
11,442,330
-962,019
| -8% | -$53.8M |
|
12
Estee Lauder
EL
$30B
| $613M | 2% |
7,072,175
-242,784
| -3% | -$20.9M |
|
13
Salesforce
CRM
$137B
| $590M | 1.92% |
8,476,738
-292,913
| -3% | -$20.9M |
|
14
Amphenol
APH
$191B
| $579M | 1.88% |
39,923,688
-1,306,632
| -3% | -$18.8M |
|
15
Ecolab
ECL
$74.8B
| $567M | 1.85% |
5,015,870
-160,725
| -3% | -$18.5M |
|
16
TripAdvisor
TRIP
$1.6B
| $548M | 1.78% |
6,288,951
+434,259
| +7% | +$35.3M |
|
|
MJN
17
DELISTED
Mead Johnson Nutrition Company
MJN
| $547M | 1.78% |
6,061,167
-261,795
| -4% | -$25.2M |
|
|
18
Costco
COST
$411B
| $538M | 1.75% |
3,984,856
+746,394
| +23% | +$107M |
|
|
19
Bristol-Myers Squibb
BMY
$125B
| $523M | 1.7% |
7,858,899
+730,906
| +10% | +$48.2M |
|
20
Cognizant
CTSH
$20.7B
| $520M | 1.69% |
8,508,597
-285,449
| -3% | -$17.9M |
|
21
NXP Semiconductors
NXPI
$68.6B
| $514M | 1.67% |
5,237,350
+150,974
| +3% | +$15.5M |
|
22
SLB Ltd
SLB
$71.1B
| $465M | 1.52% |
5,398,260
-182,989
| -3% | -$16.5M |
|
|
23
DaVita
DVA
$15.1B
| $457M | 1.49% |
5,756,414
-1,108,325
| -16% | -$91M |
|
|
24
Gilead Sciences
GILD
$164B
| $453M | 1.48% |
3,870,411
-1,030,225
| -21% | -$113M |
|
25
Fastenal
FAST
$52.1B
| $453M | 1.47% |
42,945,324
-1,635,504
| -4% | -$17.2M |
|
Similar funds
QCM
Brown Advisory's Q2 2015 Portfolio in Review
As of Q2 2015, Brown Advisory held 969 positions worth $30.7B, down 2.2% from $31.4B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Brown Advisory's Q2 2015 filing shows 40 new, 169 increased, 587 reduced and 106 closed positions. Its largest new stake was Archrock: 707,748 shares worth $23.1M. The largest sale was Whole Foods Market Inc, an estimated $144M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Brown Advisory's largest Q2 2015 buy was Archrock: 707,748 shares worth $23.1M.
- Brown Advisory added most to Alexion Pharmaceuticals in Q2 2015, an estimated $252M increase.
- Brown Advisory's biggest Q2 2015 reduction was Whole Foods Market Inc, cutting an estimated $144M.
- Brown Advisory fully exited ARUBA NETWORKS, INC. in Q2 2015, selling an estimated $38.7M.
- Brown Advisory's ten largest holdings make up 27% of its $30.7B portfolio in Q2 2015.
- Brown Advisory opened 40 new positions and closed 106 in Q2 2015.
- Brown Advisory's portfolio value fell 2.2% quarter-over-quarter to $30.7B.
Based on Brown Advisory's 13F filing for Q2 2015, filed 11 Aug 2015.